tirzepatide vs semaglutide weight loss efficacy New study result 🚨 SURMOUNT 5 RCT 📉Total body loss: −20.2% with tirzepatide −13.7% with semaglutide 🤢Discontinuations due to gastrointestinal events: tirzepatide 2.7%, semaglutide 5.6% 🤮vomiting tirzepatide 15.0 Mounjaro (Tirzepatide) vs Semaglutide |

This market is growing due to the rising global prevalence of obesity and strong clinical evidence demonstrating GLP-1 drugs' effectiveness in weight management and metabolic health

Before taking Januvia, talk with your doctor about your health history

Wegovy is a GLP-1 receptor agonist approved by the Food and Drug Administration (FDA) for chronic weight management

Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, Greig NH, Li Y, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ (2023) The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial

Nitric oxide system

G., Spahn, D